Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Seroprevalence and Risk Factors of Hepatitis C Virus Among Juveniles in Correctional Center in Isfahan, Iran



Nokhodian Z1 ; Ataei B1 ; Kassaian N1 ; Yaran M1 ; Hassannejad R1 ; Adibi P2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Gastroenterology, Integrative Functional Gastroenterology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

Source: International Journal of Preventive Medicine Published:2012

Abstract

Background and Aims: Juveniles in custody are affected by blood borne viruses due to high rates of risk behaviors. Therefore, they have a disproportionate burden of infectious diseases, such as hepatitis C virus (HCV) infection. The purpose of the present study was to determine prevalence and associated characteristics of hepatitis C infection in inmates of a correctional center in Isfahan, Iran. Methods: We conducted a cross-sectional study of HCV infection in 160 youths, who were admitted to correctional center in Isfahan during 2008-2009. Subjects were asked questions regarding behaviors that might put them at high risk for acquiring HCV and blood was drawn for this test. Sera were analyzed for HCV Ab and RIBA test was performed on antibody-positive HCV. We used Chi-square test and logistic regression model to analyze data and P < 0.05 was considered statistically significant. Results: A total of 160 young prisoners (147 boys and 13 girls) were studied. The mean age of the inmates was 16.59 ± 1.24 year. A history of intravenous drug addiction was reported in 3.8% of them. HCV infection was detected in 7 (4.4%) subjects. This study revealed that history of IDU was the main risk factor for HCV (OR, 134.44; 95% confidence interval [CI], 7.29-2481.03). Conclusion: To prevent HCV transmission, proper drug prevention educations should be performed in young age prisoners.
Related Docs
View other Related Docs
1. Hepatitis C in Correctional Centers: A Useful Experience, Journal of Isfahan Medical School (2011)
2. Hepatitis C Among Intravenous Drug Users in Isfahan, Iran: A Study of Seroprevalence and Risk Factors, International Journal of Preventive Medicine (2012)
3. The Experience of Hepatitis C Screening Among Prison Inmates With Drug Injection History, Journal of Isfahan Medical School (2011)
4. Hepatitis C Seroprevalence Among Intravenous Drug Users in Tehran, Journal of Research in Medical Sciences (2008)
5. Seroprevalence of Hepatitis B Virus and Human Immunodeficiency Virus Among Young Prisoners, Journal of Research in Medical Sciences (2013)
6. Prevalence of Hbv and Hcv Infections and Associated Risk Factors in Addict Prisoners, Iranian Journal of Public Health (2006)
7. Prevalence and Risk Factors for Hepatitis B and Hepatitis C Exposure in Iranian Prisoners: A National Study in 2016, Hepatitis Monthly (2019)
8. Hepatitis C Virus and Associated Risk Factors Among Prison Inmates With History of Drug Injection in Isfahan, Iran, International Journal of Preventive Medicine (2012)
Experts (# of related papers)
View all Related Experts
Behrooz Ataei (38)
Nazila Kassaian (28)
Other Related Docs
9. Seroprevalence of and Risk Factors Associated With Hepatitis B, Hepatitis C, and Human Immunodeficiency Virus Among Prisoners in Iran, Infectious Diseases in Clinical Practice (2007)
10. Hepatitis C Screening in Isfahan Drop in Centers: An Experience Description, Journal of Isfahan Medical School (2011)
11. Incarceration Is a Major Risk Factor for Blood-Borne Infection Among Intravenous Drug Users, Hepatitis Monthly (2011)
12. Hepatitis C in Intravenous Drug Users: Seroprevalence and Risk Factors, Journal of Isfahan Medical School (2011)
13. Seroprevalence of Hepatitis a in Patients With Chronic Hepatitis C in Isfahan Province, International Journal of Preventive Medicine (2012)
14. Hepatitis C Virus Seroprevalence and Associated Risk Factors Among Male Drug Injectors in Kermanshah, Iran, Hepatitis Monthly (2017)
15. Prevalence and Risk Factors of Hiv, Syphilis, Hepatitis B and C Among Female Prisoners in Isfahan, Iran, Hepatitis Monthly (2012)
16. Risk Prison and Hepatitis B Virus Infection Among Inmates With History of Drug Injection in Isfahan, Iran, The Scientific World Journal (2013)
17. Assessment of Hepatitis C Risk Factors in Center of Iran: A Case-Control Study, Journal of Research in Medical Sciences (2018)
18. Prevalence and Risk Factors of Hepatitis B Infection in Injection Drug Users, Tehran (2001-2002), Hepatitis Monthly (2008)
19. Seroprevalence of Hepatitis B Markers Among Incarcerated Intravenous Drug Users, Journal of Research in Medical Sciences (2014)
20. Positive Hepatitis C Virus Antibody in Cases With History of Intravenous Drug Abuse Via Community Announcement: A Useful Experience, Journal of Isfahan Medical School (2011)
21. Identification of Patients With Hepatitis C Virus Infection in Persons With Background of Intravenous Drug Use: The First Community Announcementbased Study From Iran, International Journal of Preventive Medicine (2012)
22. Hepatitis B and C Among Patients Infected With Human Immunodeficiency Virus in Isfahan, Iran: Seroprevalence and Associated Factors, Hepatitis Monthly (2010)
23. Seroprevalence of Hepatitis a Among Street Children, Isfahan, Iran, Journal of Isfahan Medical School (2012)
24. Relative Frequency of Early Virologic Response to Treatment With a Combination of Conventional Interferon and Ribavirin in Patients With Chronic Hepatitis C, Journal of Isfahan Medical School (2012)
25. Hepatitis G Virus Exposure in Dialysis Patients and Blood Donors in Isfahan-Iran, International Journal of Preventive Medicine (2014)
26. Are the Preventive Services for Hhv-8 Necessary in Hiv Positive Persons in Central Zone of Iran?, Iranian Journal of Pathology (2014)
27. Seroprevalence of Hepatitis C Infection Among Laboratory Health Care Workers in Isfahan, Iran, International Journal of Preventive Medicine (2012)
28. Hepatitis C Virus in Iran: Epidemiology of an Emerging Infection, Archives of Iranian Medicine (2005)
29. A Case-Control Study of Risk Factors for Hepatitis B Infection: A Regional Report Among Isfahanian Adults, Journal of Research in Medical Sciences (2019)
30. Hepatitis C Virus Infection in Patients With Hemophilia in Isfahan, Iran, International Journal of Preventive Medicine (2012)
31. Hepatitis C Screening in Intravenous Drug Users Under Treatment With Methadone: An Action Reserch Study, Journal of Isfahan Medical School (2011)
32. Correlation Between Il-28 Polymorphism and Spontaneous Clearance in Hcv Patients: Systematic Review and Meta-Analysis, Archives of Virology (2021)
33. Comparison of the Prevalence and Risk Factors of Hepatitis a in 10 to 18-Year-Old Adolescents of Sixteen Iranian Provinces: The Caspian-Iii Study, Hepatitis Monthly (2016)
34. Comparing the Effectiveness of a Short-Term Double-Dose Hepatitis B Vaccination Schedule With the Standard 3-Dose Schedule: A Randomized Clinical Trial, Tehran University Medical Journal (2011)
35. Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National Guideline, Hepatitis Monthly (2016)
36. Seroprevalence of Hbv, Hcv and Hiv Infection Among Intravenous Drug Users in Shahr-E-Kord, Islamic Republic of Iran, Eastern Mediterranean Health Journal (2008)
37. Hepatitis D Virus Infection in Isfahan, Central Iran: Prevalence and Risk Factors Among Chronic Hbv Infection Cases, Hepatitis Monthly (2011)
38. High Risky Behaviors Among Intravenous Drug Users in Isfahan, Iran: A Study for Hepatitis C Harm Reduction Programs, International Journal of Preventive Medicine (2012)
39. Seroepidemiology of Hepatitis a Virus Infections in Over 6-Years Population in Isfahan–Iran: A Community-Based Study, Journal of Isfahan Medical School (2007)
40. Seroprevalence of Hepatitis a Virus in Patients With Chronic Hepatitis B or C in Isfahan Province, Iran, Journal of Isfahan Medical School (2012)
41. Prevalence of Hiv/Hcv/Hbv Infections and Drug-Related Risk Behaviours Amongst Idus Recruited Through Peer-Driven Sampling in Iran, International Journal of Drug Policy (2010)
42. Hepatitis C Screening in Intravenuos Drug Users in Golpayegan, Isfahan Through Community Announcement: Pilot Study, Journal of Isfahan Medical School (2011)
43. Prevalence of Hiv Infection in Inmates With History of Injection Drug Use and Evaluation of Risk Factors, in Isfahan, Iran, Pakistan Journal of Medical Sciences (2013)
44. Hepatitis a Seropositivity Among Newly Admitted Medical Students of Isfahan, Kermanshah, and Hamedan: A Seroprevalence Study, Journal of Research in Medical Sciences (2014)
45. The Prevalence of High Risk Behaviors Among Women Prisoners in Isfahan, Iran, Journal of Isfahan Medical School (2011)
46. Hepatitis C Virus Genotype Frequency in Isfahan Province of Iran: A Descriptive Cross-Sectional Study, Virology Journal (2010)
47. Co-Infection of Human Immunodeficiency Virus, Hepatitis C and Hepatitis B Virus Among Injection Drug Users in Drop in Centers, Journal of Research in Medical Sciences (2014)
48. Correlates of Injecting Paraphernalia Sharing Among Male Drug Injectors in Kermanshah, Iran: Implications for Hcv Prevention, Journal of Substance Use (2020)
49. Seroprevalence of Hepatitis C (Hcv) and Human Immunodeficiency Virus (Hiv) Infection Among Street Children in Isfahan, Iran, Tehran University Medical Journal (2010)
50. Hepatitis B and C Among Women With Illegal Social Behavior in Isfahan, Iran: Seroprevalence and Associated Factors, Hepatitis Monthly (2011)